Skip to main content
. 2012 Dec 6;2012:386041. doi: 10.1155/2012/386041

Table 1.

Baseline characteristics.

Characteristic N (%) or mean ± SD P value for ethnicitya
White Europeans South Asians Whole population
Total (n) 134 68 202
Age, years 62.7 ± 8.1 54.9 ± 10.4 60.1 ± 9.7 <0.001
Gender
 Male 63 (47.0) 35 (51.5) 98 (48.5) 0.655
 Female 71 (53.0) 33 (48.5) 104 (51.5) 0.556
Smoking status (current) 51 (38.1) 6 (8.8) 57 (28.2) <0.001
Weight, kg 87.4 ± 18.5 75.9 ± 2.1 83.5 ± 18.5 <0.001
Waist circumference, cm 101.8 ± 15.0 98.0 ± 12.4 100.5 ± 14.3 0.096
Fasting glucose, mmol/L 6.8 ± 2.2 6.4 ± 1.4 6.7 ± 2.0 0.175
2-hour glucose, mmol/L 11.4 ± 4.2 11.3 ± 3.4 11.3 ± 3.9 0.809
HbA1c, % 6.6 ± 1.4 6.7 ± 0.9 6.6 ± 1.2 0.785
Type 2 diabetes 60 (44.8) 33 (48.5) 93 (46.0) 0.656
IGT 74 (55.2) 35 (51.5) 109 (54.0) 0.752
Blood pressure, mmHg
 Systolic 147.1 ± 17.9 141.0 ± 18.1 145.1 ± 18.2 0.041
 Diastolic 88.8 ± 9.9 87.5 ± 10.2 88.4 ± 10.1 0.446
Cholesterol, mmol/L
 Total 5.8 ± 1.2 5.0 ± 1.0 5.5 ± 1.2 <0.001
 LDL 3.6 ± 1.0 3.1 ± 0.8 3.4 ± 1.0 0.001
 HDL 1.3 ± 0.3 1.2 ± 0.3 1.3 ± 0.3 0.010
Cardiovascular medicationb 59 (42.4) 33 (48.5) 92 (45.5) 0.542

SD: standard deviation.

a P values show the difference between the two ethnic groups and were calculated using t-tests for continuous variables and Fisher's exact test for categorical variables.

bDefined as any of following prescription medications: angiotensin converting enzyme inhibitor, beta-blocker, calcium channel antagonist, statin, or fibrate lipid lowering treatments.